UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (45), p.E4869-E4877

2014

Volltextzugriff (PDF)

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2013-08, Vol.73 (16), p.5195-5205

2013

Volltextzugriff (PDF)

Facilitating a culture of responsible and effective sharing of cancer genome data

Nature medicine, 2016-05, Vol.22 (5), p.464-471

2016

Volltextzugriff (PDF)

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4676-4684

2014

Volltextzugriff (PDF)

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1 -Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade

Molecular cancer therapeutics, 2018-07, Vol.17 (7), p.1526-1539

2018

Volltextzugriff (PDF)

BRCA1/2 Variant Data-Sharing Practices

The Journal of law, medicine & ethics, 2019-03, Vol.47 (1), p.88-96

2019

Volltextzugriff (PDF)

Targeted Therapy for Squamous Cell Lung Cancer

Lung cancer management, 2012-12, Vol.1 (4), p.293-300

2012

Volltextzugriff (PDF)

Mapping the human genetic architecture of COVID-19

Nature (London), 2021-12, Vol.600 (7889), p.472-477

2021

Volltextzugriff (PDF)

A first update on mapping the human genetic architecture of COVID-19

Nature (London), 2022-08, Vol.608 (7921), p.E1-E10

2022

Volltextzugriff (PDF)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

PLoS genetics, 2018-12, Vol.14 (12), p.e1007752-e1007752

2018

Volltextzugriff (PDF)

Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

Oncogene, 2015-04, Vol.34 (17), p.2167-2177

2015

Volltextzugriff (PDF)

A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes

Diabetes (New York, N.Y.), 2017-11, Vol.66 (11), p.2903-2914

2017

Volltextzugriff (PDF)

Abstract 963: Characterizing acquired resistance mechanisms to targeted therapy in FGFR1-amplified lung squamous cell carcinoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.963-963

2013

Volltextzugriff (PDF)

Abstract B13: FGFR2 as a therapeutic target in squamous cell lung carcinoma

Clinical cancer research, 2012-02, Vol.18 (3_Supplement), p.B13-B13

2012

Volltextzugriff (PDF)

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (45), p.15872-15872

2014

Volltextzugriff (PDF)

Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale–21 (DASS-21) Across Eight Countries

Assessment (Odessa, Fla.), 2021-09, Vol.28 (6), p.1531-1544

2021

Volltextzugriff (PDF)

Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors

Plastic and reconstructive surgery (1963), 2020-05, Vol.145 (5), p.898e

2020

Volltextzugriff (PDF)

Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction

Scientific reports, 2020-01, Vol.10 (1), p.1137-1137, Article 1137

2020

Volltextzugriff (PDF)

Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors

Plastic and reconstructive surgery (1963), 2020-05, Vol.145 (5), p.898-908e

2020

Volltextzugriff (PDF)

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

Neuron (Cambridge, Mass.), 2010-12, Vol.68 (6), p.1067-1081

2010

Volltextzugriff (PDF)

Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit

The Journal of pediatrics, 2021-01, Vol.228, p.213-219

2021

Volltextzugriff (PDF)

Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2778-2785

2019

Volltextzugriff (PDF)

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

The Lancet (British edition), 2022-05, Vol.399 (10340), p.2015-2030

2022

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(61)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Humans
(37)
Life Sciences & Biomedicine
(35)
Female
(22)
Male
(18)
Middle Aged
(11)
Genomes
(10)
Multidisciplinary Sciences
(10)
Science & Technology - Other Topics
(10)
Adult
(9)
Aged
(9)
Animals
(9)
Oncology
(9)
Cancer
(8)
Mice
(8)
Mutation
(8)
Clinical Trials
(7)
Humanities And Social Sciences
(7)
Multidisciplinary
(7)
Risk Factors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Facilitating a culture of responsible and effective sharing of cancer genome data

Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC

RAS-MAPK Reactivation Facilitates Acquired Resistance in FGFR1 -Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR-MEK Blockade

BRCA1/2 Variant Data-Sharing Practices

Targeted Therapy for Squamous Cell Lung Cancer

Mapping the human genetic architecture of COVID-19

A first update on mapping the human genetic architecture of COVID-19

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells

A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes

Mapping the human genetic architecture of COVID-19

Abstract 963: Characterizing acquired resistance mechanisms to targeted therapy in FGFR1-amplified lung squamous cell carcinoma

Abstract B13: FGFR2 as a therapeutic target in squamous cell lung carcinoma

Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

Examining the Dimensionality, Reliability, and Invariance of the Depression, Anxiety, and Stress Scale–21 (DASS-21) Across Eight Countries

Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors

Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction

Prepectoral Direct-to-Implant Breast Reconstruction: Safety Outcome Endpoints and Delineation of Risk Factors

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit

Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

Suchergebnisse filtern